On September 2, 2026 Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, reported that CFO Raphi Levy will participate in the following investor conferences in September 2026.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Citi’s 2026 Biopharma Back to School Conference
Format: 1×1 Meetings
Date: Wednesday, September 9, 2026
Location: New York, NY

Event: H.C. Wainwright 28th Annual Global Investor Conference
Format: Fireside Chat and 1×1 Meetings
Date: Monday, September 14, 2026
Time: 9:30 – 10:00AM ET
Location: New York, NY

Mr. Levy will be available for 1×1 investor meetings at all conferences. Please reach out to your Citi or H.C. Wainwright representatives to schedule.

(Press release, Alpha Tau Medical, SEP 2, 2026, View Source [SID1234670565])